Management of headache

Similar documents
Management options for Migraine. Prof. Dr. Khwaja Nazimuddin Head Dept. of Internal Medicine BIRDEM

How do we treat migraine? New SIGN Guidelines

Çiçek Wöber-Bingöl HEADACHE UNIT FOR CHILDREN AND ADOLESCENCE

HMFP Comprehensive Headache Center Department of Anesthesia, Critical Care and Pain Medicine Beth Israel Deaconess Medical Center Instructor in

Medication For Migraine Chart: Table 1: Acute Treatment when the attack begins

ปวดศ รษะมา 5 ป ก นยาแก ปวดก ย งไม ข น นพ.พาว ฒ เมฆว ช ย โรงพยาบาลนครราชส มา

Recognition and treatment of medication overuse headache

COMBINATION THERAPIES PREVENTATIVE THERAPIES BETA BLOCKERS

Vestibular Migraine. Information for patients and carers. Department of Neurology and Otolaryngology Aberdeen Royal Infirmary

Faculty Disclosures. Learning Objectives. Acute Treatment Strategies

ADVANCES IN MIGRAINE MANAGEMENT

Treatments for migraine

Goals. Primary Headache Syndromes. One-Year Prevalence of Common Headache Disorders

Adult with headache. Problem-specific video guides to diagnosing patients and helping them with management and prevention

Acute Migraine Treatment: What you and your family should know to help you make the best choices with your doctor

Prednisone vs. placebo in withdrawal therapy following medication overuse headache

Update on Diagnosis and Management of Migraines

SIGN on the pharmacological management of migraine

Abortive Agents. Available Strengths. Formulary Limits. Tablet: 5mg, 10mg ODT: 5mg, 10 mg 25mg, 50mg, 100mg. 5mg/act, 20mg/act

Treatment of Primary Headache Syndromes

Dubai Standards of Care (Migraine)

MIGRAINE UPDATE. Objectives & Disclosures. Learn techniques used to diagnose headaches. Become familiar with medications used for headache treatment.

Reflections on NICE Headache Guideline. Dr Kay Kennis GPwSI in Headache, Bradford

Disclosures. Triptans for Kids 5/16/13

Headaches in Children and Adolescents. Paul Shillito

Treatment Of Medication. Overuse Headache

Migrainous headache, the menstrual cycle and pregnancy. Dr Manuela Fontebasso Headache Specialist, Author and Headache Education Facilitator

Faculty Disclosure. Karen L. Bremer, MD. Dr. Bremer has listed no financial interest/arrangement that would be considered a conflict of interest.

A case of a patient with chronic headache. Focus on Migraine. None related to the presentation Grants to conduct clinical trials from: Speaker bureau:

HEADACHE. Summary of British Association on the Study of Headaches {click to visit}

Triptans Quantity Limit Program Summary

Aleksandra Radojičić. Headache Center, Neurology Clinic, Clinical Center of Serbia

Adult & Pediatric Patients. Stanford Health Care, Division Pain Medicine

Chronic Migraine in Primary Care. December 11 th, 2017 Werner J. Becker University of Calgary

ONZETRA XSAIL (sumatriptan) nasal powder

MEASURE #1: MEDICATION PRESCRIBED FOR ACUTE MIGRAINE ATTACK Headache

Ishaq Abu Arafeh Consultant Paediatrician Royal Hospital for Children, Glasgow Forth Valley Royal Hospital, Larbert

Primary Care Adult Headache Management Pathway (formerly North West Headache Management Guideline for Adults) Version 1.0

The best defense is a good offense. Optimizing the Acute Treatment of Migraine. Disclosures 11/10/2017

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

HEADACHE: Benign or Severe Dr Gobinda Chandra Roy

Triptan Quantity Limit

An Overview of MOH. ALAN M. Rapoport, M.D. Clinical Professor of Neurology The David Geffen School of Medicine at UCLA Los Angeles, California

10/31/2017 PRIMARY CARE AND HEADACHE DISCLOSURES WHERE DO THOSE WITH HEADACHE SEEK MEDICAL CARE? Primary Care 67%

I have no financial relationships to disclose. I will not discuss investigational use of medication in my presentation.

Page: 1 of 6. Aimovig (erenumab-aooe) injection, Ajovy (fremanezumab-vfrm) injection, Emgality (galcanezumab-gnim)

Headache Master School Japan-Osaka 2016 (HMSJ-Osaka2016) October 23, II. Management of Refractory Headaches

Maternity. Migraine in pregnancy Information for women

Treatment of migraine attacks and prevention of migraine: Guidelines by the German Migraine and Headache Society and the German Society of Neurology

Anti-Migraine Agents

OH, MY ACHING HEAD! I HAVE NO DISCLOSURES OR CONFLICTS OF INTERESTS TO DECLARE MANAGING HEADACHE IN THE OUTPATIENT SETTING SECONDARY HEADACHES

Prevention and Treatment of Migraines CAITLIN BARNES, PHARM.D. CANDIDATE AMBULATORY CARE JOE CAMMILLERI, PHARM.D. NATOHYA MALLORY, PHARM.D.

BOTULINUM TOXIN POLICY TO INCLUDE:

Clinical case. Clinical case 3/15/2018 OVERVIEW. Refractory headaches and update on novel treatment. Refractory headache.

TABLE 1. Current Diagnostic Criteria for Migraine Without Aura 2 A. At least 5 attacks fulfilling criteria B-D B. Headache attacks lasting 4-72 hours

Strategies in Migraine Care

Migraine Management. Dr Helen Brown Director of Neurology and Stroke The Princess Alexandra Hospital

Case Presentation. Case Presentation. Case Presentation. Truths about Headaches (2017) Most headaches were muscle-tension headaches

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

SIGN 155 Pharmacological management of migraine. A national clinical guideline February Evidence

UTILIZATION MANAGEMENT CRITERIA

Headache A Practical Approach

Short Clinical Guidelines: Headache, Key Points for Diagnosis and Treatment

Page: 1 of 5. Sumatriptan Tablets and Nasal Spray (Imitrex) / sumatriptan and naproxen sodium (Treximet tablets)

ABORTIVE AGENTS. Average cost per 30 days. Form Limits SEROTONIN AGONISTS $ $ Reserved for treatment failure to either Sumatriptan PA; QL

Risk Factors, Clinical Course, and Barriers to Care in Adults and Pediatrics. Rebecca R. Buttaccio, PA-C Dent Neurologic Institute

Ergotamine/Dihydroergotamine Products

Acute Migraine Treatment in Adults

Preventive treatment of migraine. Rebecca Burch, MD Brigham and Women s Faulkner Hospital Harvard Medical School Boston, MA

MEASURE #3: PREVENTIVE MIGRAINE MEDICATION PRESCRIBED Headache

10/19/12. Headache: Tips and Tools for Management. Michael A. Rogawski, MD, PhD Disclosures

Chronic Daily Headaches

Jessica Ailani MD FAHS Director, Georgetown Headache Center Associate Professor Neurology Medstar Georgetown University Hospital

10/17/2017 CHRONIC MIGRAINES BOTOX: TO INJECT OR NOT INJECT? IN CHRONIC MIGRAINE PROPHYLAXIS OBJECTIVES PATIENT CASE EPIDEMIOLOGY EPIDEMIOLOGY

How could I be having migraine when I don't have a headache?

Index. Prim Care Clin Office Pract 31 (2004) Note: Page numbers of article titles are in boldface type.

Tears of Pain SUNCT and SUNA A/PROFESSOR ARUN AGGARWAL RPAH PAIN MANAGEMENT CENTRE

MEASURE #4: Overuse of Barbiturate Containing Medications for Primary Headache Disorders Headache

Management of Migraine

Migraine Acute treatment

ASEBP and ARTA TARP Drugs and Reference Price by Categories

Maxalt. Maxalt / Maxalt-MLT (rizatriptan) Description. Section: Prescription Drugs Effective Date: April 1, 2016

SUMAVEL DOSEPRO (sumatriptan succinate) solution for injection

Clinical Policy: Triptans Reference Number: CP.CPA.217 Effective Date: Last Review Date: Line of Business: Commercial

Overuse of barbiturate and opioid containing medications for primary headache disorders Description

Current Migraine Treatment Therapy. Daniel Kassicieh, DO, FAAN

Manging Migraine in Children & Adults

Drug therapy in headache

Improving Headache Care

Clinical Policy: Triptans Reference Number: CP.HNMC.217 Effective Date: Last Review Date: Line of Business: Medicaid Medi-Cal

Migraine Management. Jane Melling Headache nurse Mater Misericordiae Hospital

PRIORITIES AND CLINICAL EFFECTIVENESS FORUM MANAGEMENT OF ADULT HEADACHE

Current practice and future directions in the prevention and acute management of migraine

Migraine. What are the symptoms of a migraine attack?

Clinical Learning Days November 10, 2017

Migraine in Children. Germano Falcao, MD Pediatric Neurology 03/07/2014

Sumatriptan Tablets, Nasal Spray (Imitrex), Nasal Powder (Onzetra Xsail), sumatriptan and naproxen sodium (Treximet tablets)

Managing Headache in General Practice 2nd Edition

Lost in Translation: Making Sense of Clinical Treatment Guidelines

Headaches in the Pediatric Emergency Dept

Transcription:

Management of headache TJ Steiner Imperial College London Based on European principles of management of common headache disorders TJ Steiner, K Paemeleire, R Jensen, D Valade, L Savi, MJA Lainez, H-C Diener, P Martelletti and EGM Couturier on behalf of the European Headache Federation and Lifting The Burden: the Global Campaign to Reduce the Burden of Headache Worldwide 04/03/09 T.J Steiner 1

The common headache disorders Migraine usually episodic Tension-type headache usually episodic (frequent in 10%), but chronic in 2-3% Cluster headache episodic or less commonly chronic Medication-overuse headache chronic and daily, a complication of treatment of migraine or TTH 04/03/09 T.J Steiner 2

General principles of headache management Reassurance and explanation relieve fear of underlying disease improves adherence to treatments Trigger factors especially in migraine, are over-emphasised even when identified, may not be avoidable the only proven dietary triggers are alcohol and monosodium glutamate Follow-up the key to ensuring best outcome 04/03/09 T.J Steiner 3

Medical management of acute migraine With a range of effective drugs, all patients should climb a treatment ladder (stepped management) usually treat three attacks at each step before proceeding to the next if followed correctly, this reliably achieves the most effective and cost-effective individualised care 04/03/09 T.J Steiner 4

Step one: symptomatic therapy Simple analgesic acetylsalicylic acid 900-1000mg (adults only) or ibuprofen 400-800mg or diclofenac 50-100mg or ketoprofen 100mg or naproxen 500-1000mg Antiemetic (if needed) domperidone 20mg or metoclopramide 10mg 04/03/09 T.J Steiner 5

Principles of step one Use soluble analgesics, in adequate dosage, taken early in the attack Consider rectal administration if vomiting analgesic suppositories (diclofenac 100mg, ibuprofen 400mg, ketoprofen 100-200mg or naproxen 500-1000mg) antiemetic suppositories (domperidone 30mg or metoclopramide 20mg) Regular over-frequent use (>15 days/month) risks medication-overuse headache 04/03/09 T.J Steiner 6

Step two: specific therapy Oral solid tablets: almotriptan 12.5mg, eletriptan 20mg, 40mg, frovatriptan 2.5mg, naratriptan 2.5mg, rizatriptan 10mg (5mg for use with propranolol), sumatriptan 25mg, 50mg, 100mg, zolmitriptan 2.5mg, 5mg ergotamine tartrate 1mg, 2mg Mouth-dispersible forms: rizatriptan 10mg, sumatriptan 50mg, 100mg, zolmitriptan 2.5mg, 5mg 04/03/09 T.J Steiner 7

Step two: specific therapy non-oral formulations: suppositories: sumatriptan 25mg ergotamine tartrate 2mg nasal spray: sumatriptan 10mg (for adolescents), 20mg, zolmitriptan 2.5mg, 5mg subcutaneous injection: sumatriptan 6mg 04/03/09 T.J Steiner 8

Principles of step two Observe contra-indications to ergots and triptans Ergotamine has low efficacy and poor tolerability Triptans differ slightly, but patients vary; one triptan may work when another has not, so patients should try several, and choose Triptans work better when headache is mild Relapse affects up to 40% of responders Regular over-frequent use (>10 days/month) risks medication-overuse headache 04/03/09 T.J Steiner 9

Step three Steps one and two combined: symptomatic therapy (analgesic plus antiemetic) plus best choice of triptan 04/03/09 T.J Steiner 10

Prophylactic management of migraine Indications for adding prophylaxis: attacks cause disability on 2 days/month, and optimised acute therapy does not prevent this, and the patient is willing to take daily medication Other indications: risk of over-frequent use of acute therapy, even when it is effective in children with frequent absences from school 04/03/09 T.J Steiner 11

Prophylactic drugs with good evidence of efficacy Beta-adrenergic blockers without partial agonism: atenolol 25-100mg bd, bisoprolol 5-10mg od, metoprolol 50-100mg bd, propranolol LA 80mg od-160mg bd Topiramate 25mg od-50mg bd Sodium valproate 600-1500mg daily Flunarizine 5-10mg od Amitriptyline 10-100 mg nocte 04/03/09 T.J Steiner 12

Principles of prophylaxis of migraine Co-morbidities and contraindications guide choice Poor compliance is a major hindrance to efficacy (once-daily dosing is better for compliance) Drugs that appear ineffective should not be discontinued too soon (not <2-3 months) Failure of one drug does not predict failure of others in a different class Consider withdrawal after 4-6 months of good control If prophylaxis fails, review the diagnosis, review compliance, review other medication 04/03/09 T.J Steiner 13

Principles of management of tension-type headache Acute therapy for episodic TTH on 2 days/week, using OTC analgesics: acetylsalicylic acid 600-1000mg (adults only) ibuprofen 400-800mg paracetamol 1000mg is less effective opioids and barbiturates have no place As headache frequency increases, so does the risk of medication overuse Episodic TTH on >2 days/week and chronic TTH are indications for prophylaxis in place of acute medication 04/03/09 T.J Steiner 14

Prophylactic management of tension-type headache Not a wide range of drugs to choose from: amitriptyline, 10-100mg at night, is the drug of choice for frequent episodic or chronic TTH nortriptyline causes fewer anticholinergic sideeffects but has less good evidence of efficacy 04/03/09 T.J Steiner 15

Principles of prophylaxis of tension-type headache Dose low at start (10mg) and increase slowly Prophylaxis that appears ineffective should not be discontinued too soon (not <2-3 months) Consider withdrawal after 6 months of good control, but prolonged treatment is sometimes indicated If prophylaxis fails, review the diagnosis, review compliance, review other medication 04/03/09 T.J Steiner 16

Medical management of cluster headache The objective in both episodic and chronic cluster headache is total attack suppression but This is not always achievable Both acute medication and prophylaxis have a role in management, but preventative drugs are the mainstay of treatment Analgesics, including opioids, have no place in treating cluster headache 04/03/09 T.J Steiner 17

Acute therapies for cluster headache Sumatriptan s/c 6mg the only proven highly-effective acute treatment, but not recommended for use > twice a day Oxygen 100% at 7 l/min for up to 15 min helps some people and may be used as frequently as needed, but requires a non-rebreathing mask and regulator 04/03/09 T.J Steiner 18

Prophylactic drugs used in cluster headache Verapamil 240-960mg daily (monitor ECG) Prednisolone 60-80mg daily for 2-4 days, then reduced over 2-3 weeks (may need repeating because of relapse during dose reduction) Lithium carbonate 600-1600mg daily (monitor blood levels) Ergotamine tartrate rectally, 2-4mg daily (usually omitted every 7th day) Methysergide 1-2mg tds (interrupt for 1 month in every 6 months) 04/03/09 T.J Steiner 19

Principles of prophylaxis of cluster headache Balance efficacy against toxicity Begin prophylaxis as early as possible after the start of a new cluster bout Except for prednisolone, which is used in short courses only, discontinue by tapering 2 weeks after full remission Failure of one drug does not predict failure of others Combinations may be tried, but the potential for toxicity is high 04/03/09 T.J Steiner 20

Management of medication-overuse headache Prevention of MOH is better than cure Once MOH has developed, early intervention is important: long-term prognosis depends on the duration of medication overuse The only effective treatment is withdrawal of the overused medication(s) most successfully done abruptly hospitalisation is rarely necessary initial worsening headache is followed after 1-2 weeks by slow improvement 04/03/09 T.J Steiner 21

Always follow-up After 2-3 weeks to ensure withdrawal has been achieved Later: improvement continues over weeks to months most patients revert to their original headache type within 2 months; this will need review and management In many cases, extended support is needed: relapse rate is ~ 40% within 5 years 04/03/09 T.J Steiner 22

The End! 04/03/09 T.J Steiner 23